Skip to main content
. 2021 Nov 9;11(11):e052449. doi: 10.1136/bmjopen-2021-052449

Figure 1.

Figure 1

SINT1A study flow and time schedule for a participant with intervention until 12 months and maximum follow-up of 5.5 years. AEs, adverse events; GRS, Genetic Risk Score; SNPs, single-nucleotide polymorphisms.